UTHSC’s Professor Robert Williams Part of Global ENIGMA Consortium Effort to Crack Brain’s Genetic Code

UTHSC's Dr. Robert Williams Among Collaborators on Groundbreaking Brain Research Published in Nature
UTHSC’s Dr. Robert Williams Among Collaborators on Groundbreaking Brain Research Published in Nature

Work of global research alliance – ENIGMA — appears in Nature

In the largest collaborative study of the brain to date, researchers from the University of Tennessee Health Science Center (UTHSC) are part of a global consortium of 190 institutions working to identify eight common genetic mutations that appear to age the brain an average of three years. The discovery could lead to targeted therapies and interventions for Alzheimer’s disease, autism and other neurological conditions.

An international team of roughly 300 scientists known as the Enhancing Neuro Imaging Genetics through Meta Analysis (ENIGMA) Network pooled brain scans and genetic data worldwide to pinpoint genes that enhance or break down key brain regions in people from 33 countries. This is the first high-profile study since the National Institutes of Health (NIH) launched its Big Data to Knowledge (BD2K) centers of excellence in 2014. The research was published recently in the peer-reviewed journal Nature.

“This is a great example of how international collaboration can jumpstart high impact science and genetics. We needed a pool of 30,000 willing subjects and their DNA to drill down to these five new genes,” said Robert W. Williams, PhD, a co-investigator of ENIGMA. Dr. Williams is chair of the UTHSC Department of Genetics, Genomics and Informatics, as well as the UT-Oak Ridge National Laboratory Governor’s Chair in Computational Genomics.

The study could help identify people who would most benefit from new drugs designed to save brain cells, but more research is necessary to determine if the genetic mutations are implicated in disease.

The UTHSC team is renowned for their work on brain structure in mice. This is their first entry into the world of human genetics. They were able to help strengthen results by showing that one of the genes also works in the same way in their large family of mice. This opens up the possibility of using mouse models to test treatments.

The ENIGMA researchers screened millions of “spelling differences” in the genetic code to see which ones affected the size of key parts of the brain in magnetic resonance images (MRIs) from 30,717 individuals. The MRI analysis focused on genetic data from seven regions of the brain that coordinate movement, learning, memory and motivation. The group identified eight genetic variants associated with decreased brain volume, several found in over one-fifth of the world’s population. People who carry one of those eight mutations had, on average, smaller brain regions than brains without a mutation but of comparable age; some of the genes are implicated in cancer and mental illness.

In October 2014, the NIH invested nearly $32 million in its Big Data Initiative, creating 12 research hubs across the United States to improve the utility of biomedical data. ENIGMA, one of two BD2K centers of excellence based at the University of Southern California (USC) in Los Angeles, was awarded a total of $11 million over four years.

“ENIGMA’s scientists screen brain scans and genomes worldwide for factors that help or harm the brain — this crowd-sourcing and sheer wealth of data gives us the power to crack the brain’s genetic code,” said Paul Thompson, PhD, Keck School of Medicine of USC professor and principal investigator of the ENIGMA Center.

“The ENIGMA Center’s work uses vast datasets as engines of biomedical discovery; it shows how each individual’s genetic blueprint shapes the human brain,” said Philip Bourne, PhD, Associate Director for Data Science at the NIH. “This ‘Big Data’ alliance shows what the NIH Big Data to Knowledge Program envisions achieving with our 12 Centers of Excellence for Big Data Computing.”

Co-authors from the UT Health Science Center include Dr. Williams and Lu Lu, MD, also a professor in the Department of Genetics, Genomics and Informatics. ENIGMA was supported in part by a Consortium grant (U54 EB020403) from the NIH BD2K Initiative, supported by a cross-NIH partnership, and by public and private agencies worldwide.